reference/5357633

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/5357633

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	497
issn	1526-8209
issueIdentifier	6
pageRange	489-497
publicationName	Clinical Breast Cancer
startingPage	489
bibliographicCitation	Rugo HS, Roche H, Thomas E, Chung HC, Lerzo GL, Vasyutin I, Patel A, Vahdat L. Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials. Clin Breast Cancer. 2018 Dec;18(6):489–97. doi: 10.1016/j.clbc.2018.07.024. PMID: 30153978.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0594-7423 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02bf8abca7561f6c3b11ffd2c72aa7aa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4699063f426427b726b348e01556f61 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_79cd8ed40c5ec5027f05fa1473366603 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1308492f5b597c12ede7db6abdbeac7e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4008692912700a4a445e5ba0ed190c16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cec4d1d4198c5ad49aa37fa17cad9a5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3522-7382 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed329961d782d1cda36375269bdcd57e
date	201812
identifier	https://doi.org/10.1016/j.clbc.2018.07.024 https://pubmed.ncbi.nlm.nih.gov/30153978
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27001 https://portal.issn.org/resource/ISSN/1526-8209
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Efficacy and Safety of Ixabepilone and Capecitabine in Patients With Advanced Triple-negative Breast Cancer: a Pooled Analysis From Two Large Phase III, Randomized Clinical Trials
discusses	http://id.nlm.nih.gov/mesh/M0473543 http://id.nlm.nih.gov/mesh/M0405146 http://id.nlm.nih.gov/mesh/M0287377
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D019008 http://id.nlm.nih.gov/mesh/D064726Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005500 http://id.nlm.nih.gov/mesh/D034261Q000008 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D000069287Q000008 http://id.nlm.nih.gov/mesh/D064726Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6445540 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11451

Showing number of triples: 1 to 48 of 48.